Cite
Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.
MLA
Antimo Naspi, et al. “Insulin-like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression in Vitro and in Vivo.” PLoS ONE, vol. 9, no. 6, Jan. 2014, p. e98641. EBSCOhost, https://doi.org/10.1371/journal.pone.0098641.
APA
Antimo Naspi, Vincenzo Panasiti, Franco Abbate, Vincenzo Roberti, Valeria Devirgiliis, Michela Curzio, Martina Borghi, Francesco Lozupone, Simone Carotti, Sergio Morini, Eugenio Gaudio, Stefano Calvieri, & Paola Londei. (2014). Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo. PLoS ONE, 9(6), e98641. https://doi.org/10.1371/journal.pone.0098641
Chicago
Antimo Naspi, Vincenzo Panasiti, Franco Abbate, Vincenzo Roberti, Valeria Devirgiliis, Michela Curzio, Martina Borghi, et al. 2014. “Insulin-like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression in Vitro and in Vivo.” PLoS ONE 9 (6): e98641. doi:10.1371/journal.pone.0098641.